CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated  Other Comprehensive Loss	Non-controlling Interest	Non-controlling Interest  Corporate Joint Venture
Balance, beginning of period (in shares) at Dec. 31, 2020			129,476,914
Balance, beginning of period at Dec. 31, 2020		$ 3,593,750	$ 1	$ 2,926,773	$ (446,856)	$ 1,025,789	$ (1,166)		$ 89,209
Balance, end of period, treasury shares (in shares) at Jun. 30, 2021					32,167,192
Increase (Decrease) in Stockholders' Equity
Net income		227,198				222,168			5,030
Other comprehensive income		0
Exercise of stock options (in shares)			631,626
Exercise of stock options		12,434		12,434
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		380,009
Issuance of restricted stock units, net of shares withheld for tax	[1]	(4,857)		(4,857)
Warrant exercises (in shares)			1,704,205
Warrant exercises		$ 32,584		32,584
Repurchase of common stock (in shares)		(5,256,737)	(5,256,737)		(5,256,737)
Repurchase of common stock		$ (145,172)			$ (145,172)
Common stock surrendered in connection with warrant exercise (in shares)			(1,025,699)		1,025,699
Common stock surrendered in connection with warrant exercises		(32,587)			$ (32,587)
Stock compensation expense		10,335		10,335
Distributions to non-controlling interests of consolidated joint ventures		(24,844)							(24,844)
Changes in non-controlling interests of consolidated joint ventures		8							8
Balance, end of period (in shares) at Jun. 30, 2021			125,910,318
Balance, end of period at Jun. 30, 2021		3,668,849	$ 1	2,977,269	$ (624,615)	1,247,957	(1,166)	$ 69,403
Balance, beginning of period, treasury shares (in shares) at Dec. 31, 2020					25,884,756
Balance, beginning of period (in shares) at Mar. 31, 2021			128,736,493
Balance, beginning of period at Mar. 31, 2021		3,655,564	$ 1	2,934,111	$ (485,274)	1,123,810	(1,166)	84,082
Balance, end of period, treasury shares (in shares) at Jun. 30, 2021					32,167,192
Increase (Decrease) in Stockholders' Equity
Net income		124,755				124,147		608
Exercise of stock options (in shares)			281,951
Exercise of stock options		6,113		6,113
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		22,796
Issuance of restricted stock units, net of shares withheld for tax	[1]	(193)		(193)
Warrant exercises (in shares)			1,704,205
Warrant exercises		$ 32,584		32,584
Repurchase of common stock (in shares)		(3,809,428)	(3,809,428)		(3,809,428)
Repurchase of common stock		$ (106,754)			$ (106,754)
Common stock surrendered in connection with warrant exercise (in shares)			(1,025,699)		1,025,699
Common stock surrendered in connection with warrant exercises		(32,587)			$ (32,587)
Stock compensation expense		4,654		4,654
Distributions to non-controlling interests of consolidated joint ventures		(16,883)						(16,883)
Changes in non-controlling interests of consolidated joint ventures		1,596						1,596
Balance, end of period (in shares) at Jun. 30, 2021			125,910,318
Balance, end of period at Jun. 30, 2021		3,668,849	$ 1	2,977,269	$ (624,615)	1,247,957	(1,166)	69,403
Balance, beginning of period, treasury shares (in shares) at Mar. 31, 2021					27,332,065
Balance, beginning of period (in shares) at Dec. 31, 2021			121,833,649
Balance, beginning of period at Dec. 31, 2021		3,970,982	$ 1	2,997,211	$ (760,863)	1,688,815	689		45,129
Balance, end of period, treasury shares (in shares) at Jun. 30, 2022					45,556,244
Increase (Decrease) in Stockholders' Equity
Net income		471,615				467,690			3,925
Exercise of stock options (in shares)			131,989
Exercise of stock options		2,912		2,912
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		402,772
Issuance of restricted stock units, net of shares withheld for tax	[1]	$ (3,645)		(3,645)
Repurchase of common stock (in shares)		(8,727,685)	(8,727,685)		(8,727,685)
Repurchase of common stock		$ (230,413)			$ (230,413)
Common stock surrendered in connection with warrant exercises		0
Stock compensation expense		12,141		12,141
Distributions to non-controlling interests of consolidated joint ventures		(28,928)							(28,928)
Changes in non-controlling interests of consolidated joint ventures		(769)							$ (769)
Balance, end of period (in shares) at Jun. 30, 2022			113,640,725
Balance, end of period at Jun. 30, 2022		4,193,895	$ 1	3,008,619	$ (991,276)	2,156,505	689	19,357
Balance, beginning of period, treasury shares (in shares) at Dec. 31, 2021					36,828,559
Balance, beginning of period (in shares) at Mar. 31, 2022			120,365,390
Balance, beginning of period at Mar. 31, 2022		4,094,798	$ 1	3,002,809	$ (818,892)	1,865,518	689	44,673
Balance, end of period, treasury shares (in shares) at Jun. 30, 2022					45,556,244
Increase (Decrease) in Stockholders' Equity
Net income		293,154				290,987		2,167
Exercise of stock options (in shares)			30,913
Exercise of stock options		556		556
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		23,920
Issuance of restricted stock units, net of shares withheld for tax	[1]	$ (24)		(24)
Repurchase of common stock (in shares)		(6,779,498)	(6,779,498)		(6,779,498)
Repurchase of common stock		$ (172,384)			$ (172,384)
Stock compensation expense		5,278		5,278
Distributions to non-controlling interests of consolidated joint ventures		(27,176)						(27,176)
Changes in non-controlling interests of consolidated joint ventures		(307)						(307)
Balance, end of period (in shares) at Jun. 30, 2022			113,640,725
Balance, end of period at Jun. 30, 2022		$ 4,193,895	$ 1	$ 3,008,619	$ (991,276)	$ 2,156,505	$ 689	$ 19,357
Balance, beginning of period, treasury shares (in shares) at Mar. 31, 2022					38,776,746

[1] Dollar amount represents the value of shares withheld for taxes.